CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 18,666	$ 22,393
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	71,009	71,671
Share-based compensation expense	2,025	3,337
Income from unconsolidated joint venture	(400)	(392)
Distributions from unconsolidated joint venture	785	785
Loss on sale of real estate, net	4	0
Changes in operating assets and liabilities:
Receivables and other assets, net	(3,229)	2,275
Accounts payable and accrued liabilities	(34,131)	(27,613)
Security deposits, prepaid rent and other liabilities	(5,421)	(7,103)
Net cash provided by operating activities	49,308	65,353
Cash flows from investing activities:
Investments in real estate	(19,094)	(30,472)
Development of real estate	(10,372)	(17,096)
Proceeds from the sale of real estate	26,791	0
Capital expenditures	(28,560)	(28,931)
Collection of real estate notes receivable	0	200
Loan origination fees	325	0
Advances on real estate notes receivable	(2,270)	0
Net cash used in investing activities	(33,180)	(76,299)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	75,000	15,000
Payments on unsecured revolving credit facility	(50,000)	(15,000)
Deferred financing costs	(5,355)	0
Repurchase and cancellation of common stock	(1,641)	(3,248)
Dividends paid	(74,377)	(70,000)
Distributions paid to non-controlling interest of limited partners	(1,402)	(1,485)
Net cash used in financing activities	(57,775)	(74,733)
Net change in cash, cash equivalents and restricted cash	(41,647)	(85,679)
Cash, cash equivalents and restricted cash - beginning of period	57,069	118,765
Cash, cash equivalents and restricted cash - end of period	15,422	33,086
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income	18,666	22,393
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	71,009	71,671
Share-based compensation expense	2,025	3,337
Income from unconsolidated joint venture	(400)	(392)
Distributions from unconsolidated joint venture	785	785
Loss on sale of real estate, net	4	0
Changes in operating assets and liabilities:
Receivables and other assets, net	(3,229)	2,275
Accounts payable and accrued liabilities	(34,131)	(27,613)
Security deposits, prepaid rent and other liabilities	(5,421)	(7,103)
Net cash provided by operating activities	49,308	65,353
Cash flows from investing activities:
Investments in real estate	(19,094)	(30,472)
Development of real estate	(10,372)	(17,096)
Proceeds from the sale of real estate	26,791	0
Capital expenditures	(28,560)	(28,931)
Collection of real estate notes receivable	0	200
Loan origination fees	325	0
Advances on real estate notes receivable	(2,270)	0
Net cash used in investing activities	(33,180)	(76,299)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	75,000	15,000
Payments on unsecured revolving credit facility	(50,000)	(15,000)
Deferred financing costs	(5,355)	0
Repurchase and cancellation of general partner units	(1,641)	(3,248)
Distributions paid to general partner	(74,377)	(70,000)
Distributions paid to limited partners and redeemable non-controlling interests	(1,402)	(1,485)
Net cash used in financing activities	(57,775)	(74,733)
Net change in cash, cash equivalents and restricted cash	(41,647)	(85,679)
Cash, cash equivalents and restricted cash - beginning of period	57,069	118,765
Cash, cash equivalents and restricted cash - end of period	$ 15,422	$ 33,086